Marina Biotech, Inc. - Strategy, SWOT and Corporate Finance Report

July 2018 | 45 pages | ID: MA3B9F7677FEN
MarketLine

Abstracts

Marina Biotech, Inc. - Strategy, SWOT and Corporate Finance Report

Summary

Marina Biotech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Marina Biotech, Inc. (Marina Biotech or ‘the company’) is a biotechnology company focused on the development and commercialization of nucleic acid-based therapies to treat orphan diseases. The company provides drugs to treat hypertension, arthritis, pain and others. The company offers Prestalia, a single-pill fixed dose combination and amlodipine besylate, a calcium channel blocker for the treatment of hypertension. Its clinical development programs include IT-102 and IT-103, a celecoxib program drug for the treatment of combined arthritis pain/hypertension and the treatment of pain requiring a high dose of celecoxib; CEQ508, an oral delivery of small interfering RNA against beta-catenin, combined with IT-102 to for familial adenomatous polyposis; and CEQ508 combined with IT-103 to treat colorectal cancer. The company is into research and development of pipeline products. Marina Biotech is headquartered in City of Industry, California, the US.

Scope

• Detailed information on Marina Biotech, Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Marina Biotech, Inc. in the form of a SWOT analysis
• An in-depth view of the business model of Marina Biotech, Inc. including a breakdown and examination of key business segments
• Intelligence on Marina Biotech, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Marina Biotech, Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Marina Biotech, Inc. and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Marina Biotech, Inc. as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Marina Biotech, Inc.'s business structure, strategy and prospects.

Contents

Company Snapshot
Marina Biotech, Inc.: Company Overview
Marina Biotech, Inc.: Overview and Key Facts
Marina Biotech, Inc.: Overview
Marina Biotech, Inc.: Key Facts
Marina Biotech, Inc.: Key Employees
Marina Biotech, Inc.: Key Employee Biographies
Marina Biotech, Inc.: Major Products and Services
Marina Biotech, Inc.: Company History
Marina Biotech, Inc.: Management Statement
Marina Biotech, Inc.: Locations and Subsidiaries
Marina Biotech, Inc.: Key Competitors
Marina Biotech, Inc.: Company Analysis
Marina Biotech, Inc.: Business Description
Marina Biotech, Inc.: SWOT Analysis
Marina Biotech, Inc.: SWOT Overview
Marina Biotech, Inc.: Strengths
Marina Biotech, Inc.: Weaknesses
Marina Biotech, Inc.: Opportunities
Marina Biotech, Inc.: Threats
Marina Biotech, Inc.: Corporate Financial Deals Activity
Marina Biotech, Inc.: Financial Deals Overview
Marina Biotech, Inc.: Targets and Partners
Marina Biotech, Inc.: Top Deals 2014 - 2018YTD*
Marina Biotech, Inc.: Mergers and Acquisitions
Marina Biotech, Inc.: Capital Raising
Marina Biotech, Inc.: Partnership
Marina Biotech, Inc.: Divestments
Marina Biotech, Inc.: Recent Developments
Marina Biotech, Inc.: News and Events Summary
Marina Biotech, Inc.: Contracts
Marina Biotech, Inc.: Corporate Governance
Marina Biotech, Inc.: Financial Performance
Marina Biotech, Inc.: Market Developments
Marina Biotech, Inc.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Marina Biotech, Inc.: Key Facts
Table 2: Marina Biotech, Inc.: Key Employees
Table 3: Marina Biotech, Inc.: Locations and Subsidiaries
Table 4: Marina Biotech, Inc.: Key Competitors
Table 5: Marina Biotech, Inc.: Deal Activity by Deal Type - Volume (TTM)
Table 6: Marina Biotech, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD2018)
Table 7: Marina Biotech, Inc.: Targets and Partners
Table 8: Marina Biotech, Inc.: Top Deals 2014 - 2018YTD
Table 9: Marina Biotech, Inc.: M&A Volume and Value Trend (2014 - YTD2018)
Table 10: Marina Biotech, Inc.: Capital Raising Volume and Value Trend (2014 - YTD2018)
Table 11: Marina Biotech, Inc.: Capital Raising by Deal Type (2014 - YTD2018)
Table 12: Marina Biotech, Inc.: Partnership Volume and Value Trend (2014 - YTD2018)
Table 13: Marina Biotech, Inc.: Partnership Trend by Deal Type (2014 - YTD2018)
Table 14: Marina Biotech, Inc.: Divestments Volume and Value Trend (2014 - YTD2018)
Table 15: Marina Biotech, Inc.: News and Events Summary
Table 16: Marina Biotech, Inc.: Contracts
Table 17: Marina Biotech, Inc.: Corporate Governance
Table 18: Marina Biotech, Inc.: Financial Performance
Table 19: Marina Biotech, Inc.: Market Developments
Table 20: Marina Biotech, Inc.: Research & Development

List Of Figures

LIST OF FIGURES

Figure 1: Marina Biotech, Inc.: Deal Activity by Deal Type - Volume (TTM)
Figure 2: Marina Biotech, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD2018)
Figure 3: Marina Biotech, Inc.: M&A Volume and Value Trend (2014 - YTD2018)
Figure 4: Marina Biotech, Inc.: Capital Raising Volume and Value Trend (2014 - YTD2018)
Figure 5: Marina Biotech, Inc.: Capital Raising by Deal Type (2014 - YTD2018)
Figure 6: Marina Biotech, Inc.: Partnership Volume and Value Trend (2014 - YTD2018)
Figure 7: Marina Biotech, Inc.: Partnership Trend by Deal Type (2014 - YTD2018)
Figure 8: Marina Biotech, Inc.: Divestments Volume and Value Trend (2014 - YTD2018)